NATHBIOGEN / NSE / Crops

Nath Bio-Genes (India) Ltd

INR 169.53.08 (-3.11%) 1D

Last updated: 2026-06-16T08:00:30.120586+00:00

Price Chart

1Y Price Trend

Open200.18

High238.69

Low126.15

Close169.02

Volume12,445

Change-31.16

Change %-15.57%

Key Information

Ticker SymbolNATHBIOGEN

Current Price169.5

52-Week High238

52-Week Low126.75

Market Cap319.85

Volume12,445

ISININE448G01010

Day High172.26

Day Low167.25

Open168.95

Recommendations

Target High238

Target Low126.75

Target Mean0

Target Median0

Risk Metrics

Overall RiskBalanced risk

Board Risk43.3

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app

News

Latest stock news

Nath Bio-Genes (India) Ltd is Rated Sell - Markets Mojo14 days ago

Market news

Nath Bio-Genes (India) Ltd is Rated Sell Markets Mojo

Nath Bio-Genes (India) Ltd Upgraded to Hold on Technical and Valuation Improvements - Markets Mojo14 days ago

Market news

Nath Bio-Genes (India) Ltd Upgraded to Hold on Technical and Valuation Improvements Markets Mojo

Golden Cross Confirmed: Do Nath Bio-Genes' Other Technical Indicators Agree? - Markets Mojo15 days ago

Market news

Golden Cross Confirmed: Do Nath Bio-Genes' Other Technical Indicators Agree? Markets Mojo

Nath Bio-Genes (India) Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals - Markets Mojo21 days ago

Market news

Nath Bio-Genes (India) Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals Markets Mojo

Nath Bio-Genes (India) Ltd is Rated Strong Sell - Markets Mojo23 days ago

Market news

Nath Bio-Genes (India) Ltd is Rated Strong Sell Markets Mojo

Nath Bio-Genes Q4 FY26 Earnings Call: Revenue Up 19%, Audio Recording Submitted - scanx.trade1 month ago

Market news

Nath Bio-Genes Q4 FY26 Earnings Call: Revenue Up 19%, Audio Recording Submitted scanx.trade

Nath Bio-Genes Reports Flat Quarterly Performance Amid Mixed Financial Trends - Markets Mojo1 month ago

Market news

Nath Bio-Genes Reports Flat Quarterly Performance Amid Mixed Financial Trends Markets Mojo

Nath Bio-Genes Consolidated March 2026 Net Sales at Rs 51.59 crore, down 0.72% Y-o-Y - Moneycontrol.com1 month ago

Market news

Nath Bio-Genes Consolidated March 2026 Net Sales at Rs 51.59 crore, down 0.72% Y-o-Y Moneycontrol.com